MedImmune
North America, Louisiana, United States, Maryland
Description
MedImmune develops medicines for unmet medical needs worldwide.
Investor Profile
MedImmune has made 3 investments, with 0 in the past 12 months and 0% as lead.
Stage Focus
- Series B (67%)
- Grant (33%)
Country Focus
- United States (67%)
- Switzerland (33%)
Industry Focus
- Biotechnology
- Medical
- Therapeutics
- Genetics
- Health Care
- Biopharma
- Education
- Innovation Management
- Non Profit
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
